Evidence map›Paper›PMID 26606451›Full record

ArticleBiomaterials2016

Effect of prevascularization on in vivo vascularization of poly(propylene fumarate)/fibrin scaffolds.

Ruchi Mishra, Brianna M Roux, Megan Posukonis, Emily Bodamer, Eric M Brey, John P Fisher, David Dean

Open access · greenAbstract readComparative Study
In one paragraph

Article in Biomaterials, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
4.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 93 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Up-to-date progress in bioprinting of bone tissue.International journal of bioprinting · 2023
    Review
  14. Regenerative biomaterials · 2023
    Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Ruchi MishraDepartment of Plastic Surgery, The Ohio State University, Columbus, OH, USA.
Brianna M RouxDepartment of Biomedical Engineering, Illinois Institute of Technology, Chicago, IL, USA; Research Service, Edward Hines Jr. V.A. Hospital, Hines, IL, USA.
Megan PosukonisDepartment of Plastic Surgery, The Ohio State University, Columbus, OH, USA.
Emily BodamerDepartment of Plastic Surgery, The Ohio State University, Columbus, OH, USA.
Eric M BreyDepartment of Biomedical Engineering, Illinois Institute of Technology, Chicago, IL, USA; Research Service, Edward Hines Jr. V.A. Hospital, Hines, IL, USA.
John P FisherFischell Department of Bioengineering, University of Maryland, College Park, MD, USA.
David DeanDepartment of Plastic Surgery, The Ohio State University, Columbus, OH, USA. Electronic address: David.Dean@osumc.edu.
The Ohio State University · USIllinois Institute of Technology · USUniversity of Maryland, College Park · US

Funding

Translational Therapeutics Research Program (TT)P30CA016058 · NCI · OHIO STATE UNIVERSITY · PI Tasleem J Padamsee · 1985 to 2026
$132.3M
Application of Tubular Perfusion System (TPS) Generated Prevascularized Bone TissR01AR061460 · NIAMS · UNIV OF MARYLAND, COLLEGE PARK · PI FISHER, JOHN P · 2011 to 2014
$1.3M
Synthetic Matrices for Vascularization of Engineered TissuesI01BX000418 · VA · EDWARD HINES JR VA HOSPITAL · PI BREY, ERIC M · 2010 to 2017
–
BLRD VA I01 BX000418NCI NIH HHS P30 CA016058NIAMS NIH HHS R01 AR061460NIAMS NIH HHS R01-AR061460
6 · The paper itself

Abstract

The importance of vascularization in the field of bone tissue engineering has been established by previous studies. The present work proposes a novel poly(propylene fumarate) (PPF)/fibrin composite scaffold for the development of vascularized neobone tissue. The effect of prevascularization (i.e., in vitro pre-culture prior to implantation) with human mesenchymal stem cells (hMSCs) and human umbilical vein endothelial cells (HUVECs) on in vivo vascularization of scaffolds was determined. Five conditions were studied: no pre-culture (NP), 1 week pre-culture (1P), 2 week pre-culture (2P), 3 week pre-culture (3P), and scaffolds without cells (control, C). Scaffolds were implanted subcutaneously in a severe combined immunodeficiency (SCID) mouse model for 9 days. During in vitro studies, CD31 staining showed a significant increase in vascular network area over 3 weeks of culture. Vascular density was significantly higher in vivo when comparing the NP and 3P groups. Immunohistochemical staining of human CD-31 expression indicated spreading of vascular networks with increasing pre-culture time. These vascular networks were perfused with mouse blood indicated by perfused lectin staining in human CD-31 positive vessels. Our results demonstrate that in vitro prevascularization supports in vivo vascularization in PPF/fibrin scaffolds.

Indexed as

Tissue ScaffoldsAnimalsBiocompatible MaterialsBone and BonesCapillariesCells, CulturedFibrinFumaratesHeterograftsHumansHuman Umbilical Vein Endothelial CellsHydrogelsMiceMice, SCIDMicroscopy, ConfocalMicroscopy, FluorescenceBiocompatible MaterialsFibrinFumaratesHydrogelsPlatelet Endothelial Cell Adhesion Molecule-1poly(propylene fumarate)PolypropylenesFibrinogenHuman umbilical vein endothelial cells (HUVECs)Mesenchymal stem cells (MSCs)Poly(propylene fumarate) (PPF)Thrombin

Identifiers

PMID26606451
PMCPMC5059847
OpenAlexW1766623055

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.